June 02, 2014
A D.C. federal judge on Friday sided with the Federal Trade Commission in a dispute over whether it was allowed to require drugmakers to report more exclusive patent licenses for approval under federal merger law.
March 25, 2014
The Pharmaceutical Research and Manufacturers of America on Monday blasted the Federal Trade Commission's argument that the agency has authority to issue industry-specific requirements and urged a D.C. federal judge to vacate a rule requiring pharmaceutical companies to report more exclusive patent licenses for approval under federal merger law.
March 11, 2014
The Federal Trade Commission said Monday it has the authority to issue reporting requirements that impact just the pharmaceutical industry, and asked a Washington, D.C., federal judge to rule in its favor in a dispute over patent licenses with the Pharmaceutical Research and Manufacturers of America.
February 10, 2014
The Pharmaceutical Research and Manufacturers of America on Friday urged a D.C. federal judge to vacate a Federal Trade Commission rule requiring pharmaceutical companies to report more exclusive patent licenses for antitrust approval under federal merger law, arguing that the agency lacks the authority to target specific sectors.